Metellus Overview
Investor Type
Venture Capital
Metellus General Information
Description
Metellus is a private investment office based in Zurich, Switzerland, specialized in direct investments in technology and healthcare. The firm takes an active ownership role to enhance value creation and is actively involved in the management of a diverse portfolio of investments in private equity and venture capital. It is a member of SECA, the Swiss Private Equity & Corporate Finance Association .
Metellus
Investments
(3)
| Company Name |
Deal Date |
Deal Type |
Deal Size |
Industry |
Company Stage |
Lead Partner |
| Immune Regulation |
16-May-2018 |
Later Stage VC |
00.000 |
Drug Discovery |
Clinical Trials - Phase 1 |
0000000 00000
|
| 00000000 000000000 |
21-Oct-2015 |
00000 00000 |
00000 |
Biotechnology |
Generating Revenue |
|
| 000000 0000000000 |
28-Jul-2015 |
00000 00000 |
00000 |
Drug Discovery |
Clinical Trials - Phase 1 |
0000000 00000
|
Want to dig into this profile?
We’ll help you find what you need
Learn more
Metellus Team (4)
| Name |
Title |
Deals |
Funds |
Boards |
Office |
| Michael Albisser |
Chief Financial Officer |
|
|
0 |
Zurich, Switzerland
|
| Boris Battistini Ph.D |
Partner |
|
|
|
Zurich, Switzerland
|
| Richard Nagle |
Partner |
0 |
|
0 |
London, United Kingdom
|
1 Former Team Member